281 POSTER A phase I study of R547, a novel cyclin dependent kinase inhibitor, in patients (pts) with advanced cancer: preliminary results
EJC SUPPLEMENTS（2006）
Key words
novel cyclin,dependent kinase inhibitor,advanced cancer,r547
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined